ImageneBio Ownership | Who Owns ImageneBio?

ImageneBio Ownership Summary

ImageneBio is owned by 18.44% institutional investors, 14.24% insiders, and 67.32% retail investors. Blue owl capital lp is the largest institutional shareholder, holding 9.66% of IMA shares.

IMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ImageneBio	18.44%	14.24%	67.32%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blue owl capital lp	823.78K	9.66%	$5.68M
Vanguard group	238.00K	2.79%	$1.64M
Bml capital management	177.03K	2.08%	$1.22M
Blackrock funding, inc. /de	131.59K	1.54%	$907.95K
Monashee investment management	91.62K	1.07%	$632.18K
Renaissance	66.10K	0.78%	$456.06K
Geode capital management	54.15K	0.64%	$373.64K
Drw securities	43.77K	0.51%	$302.00K
Nano cap new millennium growth fund l p	26.50K	0.31%	$182.85M
Aldebaran capital	19.07K	0.22%	$131.58K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	177.03K	1.06%	$1.22M
Blue owl capital lp	823.78K	0.43%	$5.68M
Monashee investment management	91.62K	0.36%	$632.18K
Nano cap new millennium growth fund l p	26.50K	0.16%	$182.85M
Aldebaran capital	19.07K	0.12%	$131.58K
Drw securities	43.77K	0.01%	$302.00K
Renaissance	66.10K	0.00%	$456.06K
Fortitude family office	400.00	0.00%	$2.76K
Jane street group	14.90K	-	$102.78K
Jpmorgan chase	70.00	-	$483.00

Top Buyers

Holder	Shares	% Assets	Change
Blue owl capital lp	823.78K	0.43%	282.86K
Monashee investment management	91.62K	0.36%	91.62K
Blackrock funding, inc. /de	131.59K	-	79.48K
Drw securities	43.77K	0.01%	43.77K
Renaissance	66.10K	0.00%	28.72K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-878.52K
Atlas venture life science advisors	-	-	-377.81K
Bml capital management	177.03K	1.06%	-5.48K
Aldebaran capital	19.07K	0.12%	-492.00
Federated hermes	-	-	-204.00

New Positions

Holder	Shares	% Assets	Change	Value
Monashee investment management	91.62K	0.36%	91.62K	$632.18K
Drw securities	43.77K	0.01%	43.77K	$302.00K
Nano cap new millennium growth fund l p	26.50K	0.16%	26.50K	$182.85M
Jane street group	14.90K	-	14.90K	$102.78K
Goldman sachs group	10.95K	-	10.95K	$75.56K

Sold Out

Holder	Change
Federated hermes	-204.00
Atlas venture life science advisors	-377.81K
Deep track capital, lp	-878.52K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	13	-59.38%	1,572,270	-66.58%	18	0.61%	10	-68.75%	1	-
Sep 30, 2025	32	-	4,705,090	-	55	-	32	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 24, 2025	SLATTERY JOSEPH P	-	Buy	$95.84K
Jul 25, 2025	Bonita David P	-	Buy	$2.50M
Jul 25, 2025	Stampacchia Otello	-	Buy	$8.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	2	-
2010 Q4	-	-
2009 Q4	-	-
2009 Q2	-	-
2008 Q4	-	-

IMA Ownership FAQ

Who Owns ImageneBio?

ImageneBio shareholders are primarily institutional investors at 18.44%, followed by 14.24% insiders and 67.32% retail investors. The average institutional ownership in ImageneBio's industry, Biotech Stocks , is 384.55%, which ImageneBio falls below.

Who owns the most shares of ImageneBio?

ImageneBio’s largest shareholders are Blue owl capital lp (823.78K shares, 9.66%), Vanguard group (238K shares, 2.79%), and Bml capital management (177.03K shares, 2.08%). Together, they hold 14.53% of ImageneBio’s total shares outstanding.

Does Blackrock own ImageneBio?

BlackRock is not among the top 10 institutional shareholders of ImageneBio.

Who is ImageneBio’s biggest shareholder by percentage of total assets invested?

Bml capital management is ImageneBio’s biggest shareholder by percentage of total assets invested, with 1.06% of its assets in 177.03K ImageneBio shares, valued at 1.22M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools